China’s two Sinopharm COVID-19 vaccines have shown over 70% efficacy against symptomatic cases, but are not clear on their level of protection against severe or asymptomatic cases, according to related research. The Journal of American Medical Association study noted that interim results of a vaccine — developed by a Wuhan-based subsidiary of Sinopharm – highlighted …

The post Sinopharm vaccine 72.8% effective against symptomatic COVID-19 cases, says study appeared first on The Filipino Times.